Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14281126 | 0.80 | FAAH (0.42) | MCL1FAAHMMP2MMP9MMP8 | |
| SCHEMBL17932835 | 0.78 | CASP2 (0.53) | FAAH | |
| SCHEMBL17932834 | 0.78 | CASP2 (0.53) | FAAH | |
| SCHEMBL20431156 | 0.78 | ALDH1A1 (0.31) | — | |
| SCHEMBL2177878 | 0.77 | MCL1 (0.39) | MCL1FAAHMMP1MMP2MMP3 | |
| SCHEMBL15085712 | 0.76 | — | — | |
| SCHEMBL18664154 | 0.76 | — | — | |
| SCHEMBL13317743 | 0.73 | MCL1 (0.36) | MCL1FAAHMMP1MMP2MMP3 | |
| SCHEMBL24779309 | 0.73 | CA5B (0.39) | SMN1; SMN2KMT2A | |
| SCHEMBL17449733 | 0.73 | ALDH1A1 (0.36) | SMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10434106-B2 | Oxysterol-statin compounds for bone growth | WARSAW ORTHOPEDIC, INC. (US) | 2019-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10434106-B2 | Oxysterol-statin compounds for bone growth | HMGCR, SOST, OSBP2 | MCL1 3828/4885FAAH 4316/4885MMP1 1639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.